Before benzodiazepines came along, barbiturates were the most commonly prescribed central nervous system depressants to treat anxiety and insomnia. Barbiturates have been widely replaced by benzodiazepines for safety reasons.
Here’s where you may be wondering why barbiturates are considered unsafe.
What are barbiturates?
Barbiturates are central nervous system (CNS) depressants that were once the standard treatment for anxiety, insomnia, and seizure disorders. Today, benzodiazepines have replaced them for most clinical uses because barbiturates carry a much narrower margin between a therapeutic dose and a lethal one.
Despite their reduced medical use, barbiturate misuse still occurs. Barbiturate withdrawal carries some of the most serious medical risks of any substance, including seizures that can be fatal without proper supervision.
What drugs are considered barbiturates?
Barbiturates are derivatives of barbituric acid. They work by directly activating GABA-A receptors in the brain, which slows nerve transmission throughout the central nervous system. The sedative effect sets in within 15 to 30 minutes and can include relaxation, mild euphoria, and significantly slowed breathing.
| Drug name | Brand name | Primary medical use |
|---|---|---|
| Phenobarbital | Luminal | Seizure disorders, epilepsy |
| Butalbital | Fioricet | Tension headaches |
| Pentobarbital | Nembutal | Anesthesia, sedation |
| Secobarbital | Seconal | Short-term insomnia |
| Amobarbital | Amytal | Sedation |
Barbiturates are not appropriate for pregnant women, adults over 65, or anyone with severe respiratory or kidney disease.
Barbiturates vs. benzodiazepines
Barbiturates and benzodiazepines both enhance GABA activity in the brain, and both carry addiction risk. The mechanism and safety profile, however, differ significantly, which is why benzodiazepines replaced barbiturates for most anxiety and sleep disorders beginning in the 1970s.
Barbiturates directly open chloride ion channels in the brain, producing full CNS suppression at higher doses. The gap between a therapeutic dose and a lethal one is small. Benzodiazepines work by amplifying the brain’s natural response to GABA rather than forcing the channel open. This gives them a considerably wider safety margin and makes a fatal accidental overdose from benzodiazepines alone far less common.
| Factors | Barbiturates | Benzodiazepines |
|---|---|---|
| Mechanism | Direct chloride channel activation | GABA receptor enhancement |
| Overdose risk | High; narrow therapeutic window | Lower when taken alone |
| Addiction potential | High | Moderate to high |
| Withdrawal danger | Severe; potentially fatal | Serious; rarely fatal on its own |
| Current medical use | Seizures, anesthesia, migraines | Anxiety, insomnia, seizures |
What are the risks associated with barbiturates?
Drowsiness
Excessive drowsiness may occur with the use of barbiturates. In fact, the drowsy feeling may persist into the next day. These substances cause impaired psychomotor functioning and create a safety risk when attempting to operate vehicles or heavy machinery.
Addiction
Barbiturates are highly addictive substances. When used on a regular basis, the body will develop tolerance to their effects, leading the individual to take higher or more frequent doses in order to achieve the desired effect.
Overdose
Barbiturates are often consumed with alcohol, which only amplifies the dangerous sedative effects that can increase the risk of toxic poisoning. Barbiturates are also sometimes combined with heroin and prescription opioids.
Signs of barbiturate addiction
Barbiturates are physically addictive. Tolerance develops within weeks of regular use, which pushes people to take larger or more frequent doses to achieve the same effect. Recognizing the signs of barbiturate addiction early reduces the risk of a dangerous withdrawal later.
Signs include:
- Taking higher doses than prescribed or using the drug longer than intended
- Strong cravings between doses
- Continued use despite problems at work, in relationships, or with health
- Seeking the drug from multiple sources or doctors
- Feeling unable to function normally without it
Treatment for barbiturate use disorder
Medically supervised detox addresses physical dependence, but it does not treat the behavioral and psychological patterns that drove the use. Sustained recovery from barbiturate use disorder requires a structured treatment program that addresses both.
At Ashley Addiction Treatment, treatment for barbiturate use disorder includes:
- Medical detox: Ashley’s drug detox program provides 24-hour monitoring through the withdrawal management process. Physicians manage symptoms and adjust the taper schedule as needed based on the patient’s response.
- Individual therapy: Ashley’s evidence-based therapies, including cognitive behavioral therapy, help patients identify the triggers and thought patterns connected to their substance use and build practical strategies for managing them.
- Group therapy: Ashley’s clinical care program incorporates peer support groups that reduce isolation and build accountability. Patients share experiences with others at similar stages of recovery, which strengthens the overall treatment experience.
- Relapse prevention planning: Working with a counselor, patients identify their specific high-risk situations and build a concrete response plan before leaving treatment. Ashley’s relapse prevention program continues this work beyond the primary treatment phase.
- Addiction aftercare program: An addiction aftercare program bridges the gap between inpatient treatment and independent recovery. Ashley’s outpatient care options include ongoing therapy, alumni programming, and community resources that extend support well beyond discharge.
Getting help for barbiturate dependence in Maryland
Barbiturate dependence responds well to treatment when it starts with proper medical detox. Ashley Addiction Treatment operates three locations in Maryland: inpatient residential care at the main campus in Havre de Grace and outpatient services in Bel Air.
If you or someone you care about is using barbiturates and struggling to stop, or is showing signs of withdrawal, Maryland detox services are available now. Call Ashley at 800-799-4673 or submit an admissions inquiry online.
Ashley Addiction Treatment, formerly Father Martin’s Ashley, is a nationally recognized nonprofit leader in integrated, evidence-based treatment for substance use disorders. Our programs are accredited by The Joint Commission, and result in frequent publications of ongoing research into effective treatment methodologies. We offer holistic care that encompasses the mind, body and spirit through inpatient and outpatient treatment, provide drug detox, relapse prevention plans, family wellness programs and a variety of other services tailored to each patient’s unique needs. Our driving principle — “everything for recovery” — reinforces our mission to transform and save lives through the science of medicine, the art of therapy and the compassion of spirituality, and is complemented by our philosophy of healing with respect and dignity. For information about our comprehensive programs, please call 866-313-6307.
